Godavari Drugs

{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "86.00",
    "chg": 0.32,
    "chgp": "0.37%",
    "dir": 1,
    "prev_price": "85.68",
    "mcapval": "87.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE362C01012",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "8.0 k",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-3919049",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_mojoScore_3919049.png",
        "date": "2026-03-27 10:10:03",
        "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-3893354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_mojoScore_3893354.png",
        "date": "2026-03-16 10:10:02",
        "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Godavari Drugs Ltd Gains 6.83%: Technical Signals Drive Weekly Rally Amid Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-gains-683-technical-signals-drive-weekly-rally-amid-fundamental-challenges-3891653",
        "imagepath": "",
        "date": "2026-03-14 17:04:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 02:</strong> Stock opens at Rs.75.58 amid broad market weakness</p>\n                    <p><strong>Mar 04:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>Mar 05:</strong> Upgrade to Sell rating on technical improvement</p>\n                    <p><strong>Mar 06:</strong> Stock surges 7.44% to close at Rs.83.02</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.75.58</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.83.02</div><di..."
      },
      {
        "title": "Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-valuation-shifts-signal-renewed-price-attractiveness-3878824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_valuationdot_3878824.png",
        "date": "2026-03-09 08:00:39",
        "description": "Godavari Drugs Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price metrics despite a challenging market backdrop. This article analyses the recent changes in the company’s price-to-earnings and price-to-book ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors."
      },
      {
        "title": "Godavari Drugs Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-upgraded-to-sell-on-technical-improvement-despite-weak-fundamentals-3872786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_mojoScore_3872786.png",
        "date": "2026-03-05 08:08:10",
        "description": "Godavari Drugs Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 4 March 2026, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and overall quality assessments. Despite some mild improvements in technical signals, the company’s weak long-term fundamentals and flat recent financial performance have weighed heavily on investor sentiment."
      },
      {
        "title": "Godavari Drugs Ltd Forms Golden Cross, Indicating Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-forms-golden-cross-indicating-potential-bullish-breakout-3870618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GodavariDrugsLt_goldencross_3870618.png",
        "date": "2026-03-04 18:00:11",
        "description": "Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-day moving average. This development often signals a potential bullish breakout and a shift in long-term momentum, attracting investor attention despite the company’s current strong sell rating and subdued financial performance."
      },
      {
        "title": "Godavari Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3852277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GodavariDrugsLt_mojoScore_3852277.png",
        "date": "2026-02-24 08:10:50",
        "description": "Godavari Drugs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This shift reflects deteriorating technical indicators, flat financial performance, and a cautious outlook on valuation and quality metrics, signalling increased risk for investors amid challenging market conditions."
      },
      {
        "title": "Godavari Drugs Ltd Falls 3.99%: Valuation Gains Amid Flat Financials Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-falls-399-valuation-gains-amid-flat-financials-shape-the-week-3849734",
        "imagepath": "",
        "date": "2026-02-21 15:02:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Stock opens at Rs.88.19, gaining 1.07% amid positive market sentiment</p>\n                    <p><strong>18 Feb:</strong> Mojo Grade upgraded to 'Sell' on valuation improvement despite flat financials</p>\n                    <p><strong>19 Feb:</strong> Stock declines 3.48% following rating upgrade and valuation shift</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.83.78, down 1.87% on the day and 3.99% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.87.26</div></div>\n                    <div class=\"stat..."
      },
      {
        "title": "Godavari Drugs Ltd Upgraded to Sell on Valuation Improvement Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-upgraded-to-sell-on-valuation-improvement-despite-flat-financials-3846406",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GodavariDrugsLt_mojoScore_3846406.png",
        "date": "2026-02-19 08:07:23",
        "description": "Godavari Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in valuation metrics despite ongoing challenges in financial performance and market returns. The pharmaceutical company’s recent assessment highlights a very attractive valuation grade, while quality, financial trends, and technical indicators remain subdued, reflecting a cautious outlook for investors."
      }
    ],
    "total": 168,
    "sid": "765253",
    "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "Intimation of Trading Window Closure",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "23-Mar-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prashant Shrimal",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "23-Mar-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Priyanka Jaju Mukund Kakani Prashant Shrimal Leshir Jaju Kamala Jaju Sushma Kakani Ghanshyam Jaju Aksheit Kakani Mohit Jaju Tanushree Kakani",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Godavari Drugs Ltd is Rated Sell

2026-03-27 10:10:03

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Godavari Drugs Ltd is Rated Sell

2026-03-16 10:10:02

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Godavari Drugs Ltd Gains 6.83%: Technical Signals Drive Weekly Rally Amid Fundamental Challenges

2026-03-14 17:04:49

Key Events This Week

Mar 02: Stock opens at Rs.75.58 amid broad market weakness

Mar 04: Golden Cross formation signals potential bullish breakout

Mar 05: Upgrade to Sell rating on technical improvement

Mar 06: Stock surges 7.44% to close at Rs.83.02

Week Open

Rs.75.58

Week Close

Rs.83.02

Read full news article

Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-09 08:00:39

Godavari Drugs Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price metrics despite a challenging market backdrop. This article analyses the recent changes in the company’s price-to-earnings and price-to-book ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors.

Read full news article

Godavari Drugs Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals

2026-03-05 08:08:10

Godavari Drugs Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 4 March 2026, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and overall quality assessments. Despite some mild improvements in technical signals, the company’s weak long-term fundamentals and flat recent financial performance have weighed heavily on investor sentiment.

Read full news article

Godavari Drugs Ltd Forms Golden Cross, Indicating Potential Bullish Breakout

2026-03-04 18:00:11

Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-day moving average. This development often signals a potential bullish breakout and a shift in long-term momentum, attracting investor attention despite the company’s current strong sell rating and subdued financial performance.

Read full news article

Godavari Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-02-24 08:10:50

Godavari Drugs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 23 February 2026. This shift reflects deteriorating technical indicators, flat financial performance, and a cautious outlook on valuation and quality metrics, signalling increased risk for investors amid challenging market conditions.

Read full news article

Godavari Drugs Ltd Falls 3.99%: Valuation Gains Amid Flat Financials Shape the Week

2026-02-21 15:02:58

Key Events This Week

16 Feb: Stock opens at Rs.88.19, gaining 1.07% amid positive market sentiment

18 Feb: Mojo Grade upgraded to 'Sell' on valuation improvement despite flat financials

19 Feb: Stock declines 3.48% following rating upgrade and valuation shift

20 Feb: Week closes at Rs.83.78, down 1.87% on the day and 3.99% for the week

Week Open

Rs.87.26

Read full news article

Godavari Drugs Ltd Upgraded to Sell on Valuation Improvement Despite Flat Financials

2026-02-19 08:07:23

Godavari Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a marked improvement in valuation metrics despite ongoing challenges in financial performance and market returns. The pharmaceutical company’s recent assessment highlights a very attractive valuation grade, while quality, financial trends, and technical indicators remain subdued, reflecting a cautious outlook for investors.

Read full news article

View All News